Abstract

CANDIDATE DRUGS AGAINST COVID-19

Dinesh P. Kawade, *Srushti L. Wairagade, Vishal D. Dakhale, Kanchan R. Ghode, Shubhangi A. Choudhari

ABSTRACT

Scientist have recommended dozens of current compounds for testing of coronavirus, however WHO is focusing on the four most promising therapies: an experimental antiviral compound known as remdesivir; the malaria medications chloroquine and hydroxychloroquine; a aggregate of two HIV drugs, lopinavir and ritonavir; and that identical mixture plus interferon-beta, an immune system messenger that can triple viruses. Some on their use in COVID-19 affected person have already emerged -HIV combo failed in small learn about in China but WHO believes a giant trial with higher range of suffers is warranted. The essential goal in the back of imparting this paper tries to discuss about how all above mention drugs shows their action on corona virus as well as dose, mechanism, interactions, toxicity etc.

Keywords: COVID-19, remdesivir, chloroquine and hydroxychloroquine, lopinavir and ritonavir, immune system.